Retirement Systems of Alabama lowered its stake in Genpact Limited (NYSE:G - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 406,445 shares of the business services provider's stock after selling 28,160 shares during the quarter. Retirement Systems of Alabama owned about 0.23% of Genpact worth $17,457,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of G. ARGA Investment Management LP raised its position in shares of Genpact by 14.1% during the 4th quarter. ARGA Investment Management LP now owns 772,917 shares of the business services provider's stock valued at $33,197,000 after buying an additional 95,413 shares in the last quarter. Trust Point Inc. purchased a new stake in shares of Genpact during the 4th quarter valued at about $214,000. Sylvest Advisors LLC purchased a new stake in shares of Genpact during the 4th quarter valued at about $737,000. Caprock Group LLC raised its position in shares of Genpact by 22.9% during the 4th quarter. Caprock Group LLC now owns 11,938 shares of the business services provider's stock valued at $513,000 after buying an additional 2,222 shares in the last quarter. Finally, KBC Group NV purchased a new stake in shares of Genpact during the 4th quarter valued at about $298,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Analysts Set New Price Targets
G has been the topic of several recent research reports. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho increased their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the stock from $45.00 to $60.00 in a research report on Friday. Needham & Company LLC increased their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday. Finally, Robert W. Baird increased their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $48.44.
Check Out Our Latest Stock Analysis on Genpact
Insider Activity
In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares of the company's stock, valued at $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,058 shares of company stock worth $1,558,675. Corporate insiders own 2.80% of the company's stock.
Genpact Trading Down 0.4 %
G stock traded down $0.24 during mid-day trading on Monday, reaching $54.71. The company had a trading volume of 1,335,612 shares, compared to its average volume of 1,452,103. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The company has a market capitalization of $9.65 billion, a PE ratio of 19.30, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20. The firm has a 50 day moving average of $45.09 and a 200 day moving average of $41.41. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.61% and a net margin of 10.77%. On average, equities analysts predict that Genpact Limited will post 3.08 earnings per share for the current fiscal year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.24%. Genpact's dividend payout ratio (DPR) is currently 23.94%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report